Breakthrough Chemistry, Inc.
BKTH
$0.158
$0.04236.21%
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 19.10K | 19.00K | 18.90K | 11.30K | 13.90K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.10K | 19.00K | 18.90K | 11.30K | 13.90K |
| Cost of Revenue | 17.80K | 17.80K | 17.80K | 2.50K | 8.80K |
| Gross Profit | 1.30K | 1.20K | 1.10K | 8.90K | 5.20K |
| SG&A Expenses | 153.30K | 149.00K | 144.70K | 124.70K | 101.40K |
| Depreciation & Amortization | 44.90K | 44.90K | 44.90K | 43.90K | 38.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 213.30K | 208.90K | 204.50K | 171.70K | 149.10K |
| Operating Income | -193.90K | -189.70K | -185.50K | -160.40K | -135.20K |
| Income Before Tax | -222.00K | -221.30K | -220.60K | -207.90K | -187.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.22 | -0.22 | -0.22 | -0.21 | -0.19 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -222.00K | -221.30K | -220.60K | -207.90K | -187.50K |
| EBIT | -193.90K | -189.70K | -185.50K | -160.40K | -135.20K |
| EBITDA | -149.20K | -144.90K | -140.60K | -116.40K | -97.30K |
| EPS Basic | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 38.91M | 38.28M | 37.65M | 36.91M | 36.17M |
| Average Diluted Shares Outstanding | 38.91M | 38.28M | 37.65M | 36.91M | 36.17M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |